Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma

Overview of attention for article published in American Journal of Physiology: Endocrinology & Metabolism, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#24 of 2,801)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 30 X posts from 18 X users, with an upper bound of 223,440 followers.

RT @APSPublications: 🎉Congratulations to @rachelperrylab1 Xinyi Zhang et al. on winning November's #APSselect award 🏆in @ajpendometab for…

🎉Congratulations to @rachelperrylab1 Xinyi Zhang et al. on winning November's #APSselect award 🏆in @ajpendometab for their article "Dichloroacetate as a novel pharmaceutical treatment for cancer-related #fatigue in #melanoma" ➡️ https://t.co/QUvxoNF0lr #

RT @APSPhysiology: #APSselect study from @AJPEndoMetab identifies dichloroacetate as a possible new drug treatment for cancer-related fatig…

RT @RachelPerryLab1: Thank you @APSPhysiology @AJPEndoMetab for highlighting our manuscript as a November #APSselect study! @YaleCancer @Ya…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 26 additional X posts.